FITCHBURG, Mass., Nov. 1 /PRNewswire-FirstCall/ -- Integrated Pharmaceuticals, Inc. (IntePharm) (OTC:INTP) announced today that it has started shipping its proprietary calcium supplement product. In addition to its calcium product, the Company is also routinely shipping other portfolio products from its Fitchburg facility to its distributors. IntePharm's specialty calcium product can be added to hot and cold beverages and does not noticeably affect the taste or flavor of the beverage. It makes more than 98% of its calcium available for absorption. "To the best of IntePharm's knowledge, no other manufacturer has a similar product on the market," said Dr. Chinmay Chatterjee, President and CEO of Integrated Pharmaceuticals, Inc. Dr. Chatterjee mentioned that its calcium product will provide one of the most essential minerals of human body, calcium, in a very user friendly manner in every drink. According to USDA, the Center for Disease Control (CDC), and the Office of Women's Health, 2000, over 90% of females, 70% of infants, 66% of children and 60% of men are calcium deficient every day. "This is a very alarming statistic. We are proud that IntePharm is continuously working to bring an effective solution for this large and long lasting worldwide problem," said Dr. Chatterjee. "Taking adequate amounts of calcium every day in the most absorbable format should be one of the lifestyle choices, like maintaining appropriate weight and a weight-bearing exercise regimen that plays a significant positive role in maintaining bone health." A large number of scientific studies confirm the important role of calcium in human metabolism, especially in the prevention of age-related bone loss, osteoporosis and high blood pressure. Several recent studies suggest that calcium may have a positive effect on other chronic disorders. Shortage of calcium through low regular calcium intake has been associated with an increased risk for colon cancer, kidney stones, toxemia of pregnancy, pre- menstrual syndrome, obesity, and polycystic ovary syndrome in addition to low bone mass/osteoporosis and high blood pressure. "All of these chronic diseases are multifactorial, and low calcium intake is only one aspect involved in each condition," according to The National Calcium Initiative: A Strategic Overview published by the State of Indiana in the year 2000. Dr. Chatterjee said that IntePharm, with its intellectual property portfolio, is uniquely positioned to deliver specialty application products to the growing demand of pharmaceutical, new generation nutraceutical, functional food and beverage industries. In recent years the market for functional food is growing with understanding of diet/disease links, aging population, rising health care costs, and advances in biochemistry, food science, and knowledge in nutrition sciences. Nutraceutical World, October 2005, reported the recent market studies indicate the total functional beverage market grew 18% over the last year and is currently posting total sales of $1.8 billion, which includes beverages sold in both the natural and conventional channels of distribution. It is expected that just the lifestyle/wellness category may register $1 billion in sales this year, as it continues to register double-digit growth. IntePharm's mineral delivery products may become one of the pioneering ingredients in these drinks. IntePharm is in active discussion with several nationwide manufacturers, distributors and retailers for distribution of its calcium product. "With expected increases of current sales, IntePharm anticipates to become cash flow positive by the third quarter 2006," said Dr. Chatterjee. About IntePharm IntePharm is an emerging producer of pharmaceuticals, specialty compounds for the pharmaceutical, nutraceutical and functional food and beverage industries. In addition to manufacturing products, IntePharm discovers and develops more efficient and cost-effective manufacturing and mineral delivery processes. These processes are developed using a comprehensive technology platform that combines metabolic engineering, cellular genetics, advanced bioprocess engineering, and computer simulation science. The company owns several other pending patents for new products and technologies for immediate commercialization in food and nutritional products market. For further information please contact Dr. Chinmay Chatterjee, Integrated Pharmaceuticals, Inc. (IntePharm), at (978) 696-0020, or visit http://www.intepharm.com/ DATASOURCE: Integrated Pharmaceuticals, Inc. CONTACT: Dr. Chinmay Chatterjee, President and CEO of Integrated Pharmaceuticals, Inc., +1-978-696-0020 Web site: http://www.intepharm.com/

Copyright